Evidence map›Paper›PMID 29855173›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2018

T Cell-Dependent Affinity Maturation and Innate Immune Pathways Differentially Drive Autoreactive B Cell Responses in Rheumatoid Arthritis.

Daniel R Lu, Andrew N McDavid, Sarah Kongpachith, Nithya Lingampalli, Jacob Glanville, Chia-Hsin Ju, Raphael Gottardo, William H Robinson

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Cross-presentation of citrullinated antigens drives cytotoxic CD8bioRxiv : the preprint server for biology · 2026
    Article
  5. Pathogenic Role of Cytokines in Rheumatoid Arthritis.Journal of clinical medicine · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniel R LuStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.
Andrew N McDavidUniversity of Rochester Medical Center, Rochester, New York.
Sarah KongpachithStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.
Nithya LingampalliStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.
Jacob GlanvilleStanford University, Stanford, California.
Chia-Hsin JuStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.
Raphael GottardoFred Hutchinson Cancer Research Center, Seattle, Washington.
William H RobinsonStanford University, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.ORCID 0000-0003-4385-704X
VA Palo Alto Health Care System · USFred Hutch Cancer Center · USStanford University · USUniversity of Rochester Medical Center · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid ArthritisU01AI101981 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2012 to 2021
$6.2M
Ultra-Fast Epigenomic Maps for Monitoring AutoimmunityU19AI110491 · NIAID · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H · 2014 to 2018
$3.6M
Stanford Technology Accelerating Medicines Partnership CenterUH2AR067676 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H, UTZ, PAUL JOSEPH · 2014 to 2020
$2.6M
Large-Scale Characterization of Autoantibody Responses in Rheumatoid ArthritisR01AR063676 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H · 2013 to 2017
$1.7M
NIAID NIH HHS U01 AI101981NIAID NIH HHS U01-AI-101981NIAID NIH HHS U19 AI110491NIAID NIH HHS U19-AI-11049103NIAMS NIH HHS R01 AR063676NIAMS NIH HHS R01-AR-063676NIAMS NIH HHS UH2-AR-067676
6 · The paper itself

Abstract

objectiveRheumatoid arthritis (RA) is characterized by the activation of B cells that produce anti-citrullinated protein antibodies (ACPAs) and rheumatoid factors (RFs), but the mechanisms by which tolerance is broken in these B cells remain incompletely understood. We undertook this study to investigate whether ACPA+ and RF+ B cells break tolerance through distinct molecular mechanisms.

methodsWe developed antigen-tetramers to isolate ACPA+ and RF+ B cells and performed single-cell RNA sequencing on 2,349 B cells from 6 RA patients and 1 healthy donor to analyze their immunoglobulin repertoires and transcriptional programs. Prominent immunoglobulins were expressed as monoclonal antibodies and tested for autoantigen reactivity.

resultsACPA+ and RF+ B cells were enriched in the peripheral blood of RA patients relative to healthy controls. Characterization of patient-derived monoclonal antibodies confirmed ACPA and RF targeting of tetramer-specific B cells at both antigen-inexperienced and affinity-matured B cell stages. ACPA+ B cells used more class-switched isotypes and exhibited more somatic hypermutations relative to RF+ B cells, and these differences were accompanied by down-regulation of CD72 and up-regulation of genes that promote class-switching and T cell-dependent responses. In contrast, RF+ B cells expressed transcriptional programs that stimulate rapid memory reactivation through multiple innate immune pathways. Coexpression analysis revealed that ACPA+ and RF+ B cell-enriched genes belong to distinct transcriptional regulatory networks.

conclusionOur findings suggest that ACPA+ and RF+ B cells are imprinted with distinct transcriptional programs, which suggests that these autoantibodies associated with increased inflammation in RA arise from 2 different molecular mechanisms.

Indexed as

AgedAged, 80 and overAntibody AffinityAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidAutoantigensAutoimmunityB-LymphocytesCase-Control StudiesFemaleGene Expression RegulationHigh-Throughput Nucleotide SequencingHumansImmunity, InnateImmunoglobulin Class SwitchingImmunologic MemoryAnti-Citrullinated Protein AntibodiesAutoantigensRheumatoid Factor

Identifiers

PMID29855173
PMCPMC6203609
OpenAlexW2806040990

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.